Generation of pancreatic β cells for treatment of diabetes: advances and challenges
Abstract Human embryonic stem cells (hESC) and induced pluripotent stem cells (hiPSC) are considered attractive sources of pancreatic β cells and islet organoids. Recently, several reports presented that hESC/iPSC-derived cells enriched with specific transcription factors can form glucose-responsive...
Main Authors: | Hussain Md. Shahjalal, Ahmed Abdal Dayem, Kyung Min Lim, Tak-il Jeon, Ssang-Goo Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-018-1099-3 |
Similar Items
-
Neural Stem Cells and Methods for Their Generation From Induced Pluripotent Stem Cells in vitro
by: Adelya A. Galiakberova, et al.
Published: (2020-10-01) -
Comparing ESC and iPSC—Based Models for Human Genetic Disorders
by: Tomer Halevy, et al.
Published: (2014-10-01) -
Perspective on human pluripotent stem cell‐derived cardiomyocytes in heart disease modeling and repair
by: Qiang Li, et al.
Published: (2020-10-01) -
Simple Derivation of Spinal Motor Neurons from ESCs/iPSCs Using Sendai Virus Vectors
by: Kazuya Goto, et al.
Published: (2017-03-01) -
Experimental and Therapeutic Opportunities for Stem Cells in Multiple Sclerosis
by: Rickie Patani, et al.
Published: (2012-11-01)